Latest news
Explore AI Communications Growth: Pathos Communications (LSE:NEWS) in Focus - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 13:47:00 GMTPathos Communications hails "record" trading month in July - London South EastLondon South East · Thu, 06 Aug 2026 12:23:00 GMTCavendish sticks with 42p target as Pathos shares recover ground - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 08:49:00 GMTPathos Communications hails record July performance - Yahoo Finance UKYahoo Finance UK · Thu, 06 Aug 2026 06:39:00 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity NewsMedCity News · Tue, 04 Aug 2026 20:22:15 GMTPathos AI Enters Two lIcensing Deals | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 19:07:22 GMTPathos AI Licenses Alphamab's TROP2/HER3 Bispecific ADC, JSKN016 - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 17:01:14 GMTEyes on Asia: Axiom, Pathos AI, Samsung Biologics - BioXconomyBioXconomy · Tue, 04 Aug 2026 15:19:19 GMT